Scholar IQ
Try ScholarIQ free
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Colorado Blood Cancer Institute

InstitutionResearch output, impact & collaborations

Colorado Blood Cancer Institute is a institution indexed in ScholarIQ from OpenAlex.

What is known about Colorado Blood Cancer Institute?

ScholarIQrecord summary

Colorado Blood Cancer Institute is a research organisation in Denver, United States. OpenAlex records 601 works and 40,409 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Colorado Blood Cancer Institute have?

ScholarIQindexed works

Colorado Blood Cancer Institute has 601 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Colorado Blood Cancer Institute have?

ScholarIQcitation count

Colorado Blood Cancer Institute has 40,409 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Colorado Blood Cancer Institute?

ScholarIQresearcher count

Colorado Blood Cancer Institute has 1 researchers in the ScholarIQ index.

What is the average h-index at Colorado Blood Cancer Institute?

ScholarIQavg h-index

Colorado Blood Cancer Institute has an average h-index of 60 in OpenAlex.

What is the ROR of Colorado Blood Cancer Institute?

ScholarIQror

The ROR for Colorado Blood Cancer Institute is on the source record.

What is the OpenAlex record for Colorado Blood Cancer Institute?

ScholarIQopenalex

The OpenAlex for Colorado Blood Cancer Institute is on the source record.

Who are the most-cited researchers behind Colorado Blood Cancer Institute?

ScholarIQtop researchers by citations
1
Michael B. Maris · Hematopoietic Stem Cell Transplantation
242 works16,929 citations

What are the most-cited papers on Colorado Blood Cancer Institute?

ScholarIQmost cited works
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer, Georg‐Nikolaus Franke, Ginna G. Laport, Thomas R. Chauncey, Edward Agura, Richard T. Maziarz, Amelia Langston, Parameswaran Hari, Michael A. Pulsipher, Wolfgang Bethge, Firoozeh Sahebi, Benedetto Bruno, Michael B. Maris, Andrew M. Yeager, Finn Bo Petersen, Lars L. Vindeløv, Peter A. McSweeney, Kai Hübel, Marco Mielcarek, George E. Georges, Dietger Niederwieser, Karl G. Blume, David G. Maloney, Rainer Storb
JAMA. 2011321 CitationsOPEN ACCESS
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation
Rainer Storb, Boglarka Gyurkocza, Barry E. Storer, Mohamed L. Sorror, Karl G. Blume, Dietger Niederwieser, Thomas R. Chauncey, Michael A. Pulsipher, Finn Bo Petersen, Firoozeh Sahebi, Edward Agura, Parameswaran Hari, Benedetto Bruno, Peter A. McSweeney, Michael B. Maris, Richard T. Maziarz, Amelia Langston, Wolfgang Bethge, Lars L. Vindeløv, Georg‐Nikolaus Franke, Ginna G. Laport, Andrew M. Yeager, Kai Hübel, H. Joachim Deeg, George E. Georges, Mary E.D. Flowers, Paul J. Martin, Marco Mielcarek, Ann E. Woolfrey, David G. Maloney, Brenda M. Sandmaier
Journal of Clinical Oncology. 2013212 CitationsOPEN ACCESS
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
David P. Steensma, Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji, Jay Yang, Andrew M. Brunner, Hetty E. Carraway, Lionel Adès, Aref Al‐Kali, Juan Manuel Alonso‐Domínguez, Ana Alfonso Piérola, Catherine C. Coombs, H. Joachim Deeg, Ian W. Flinn, James M. Foran, Guillermo Garcia‐Manero, Michael B. Maris, Malgorzata McMasters, Jean‐Baptiste Micol, Jaime Pérez de Oteyza, Felicitas Thol, Eunice S. Wang, Justin M. Watts, Justin Taylor, Richard M. Stone, Vikram Gourineni, Alyssa J. Marino, Huilan Yao, Benoit Destenaves, Xiaobin Yuan, Kun Yu, Sara Dar, Lernik Ohanjanian, Keisuke Kuida, Jianjun Xiao, Catherine Scholz, Antonio Gualberto, Uwe Platzbecker
Leukemia. 2021184 CitationsOPEN ACCESS

How much of the research on Colorado Blood Cancer Institute is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
67%
Bronze
33%
Closed
0%
470M+ articles · free account